NEW YORK, NY / ACCESSWIRE / July 13, 2017 / U.S. markets rose Wednesday as investors reacted positively to Federal Reserve Chairwoman Janet Yellen's congressional testimony. The Dow Jones Industrial Average hit a new intra-day high of 21,580.79, before settling to close at 21,553.61, an increase of 0.68 percent. The S&P 500 Index gained 0.79 percent to close at 2,444.72.

"It seems like [Yellen's] dialing back a little bit of the hawkish sentiment from last time," said Karyn Cavanaugh, Senior Market Strategist at Voya Financial. "She's back to looking at inflation a little bit more. The market was a little worried but she's back to the same dovish Yellen."

Technology and Healthcare have been the top performing sectors in the S&P 500 Index in 2017, with gains of approximately 19 percent and 16 percent, respectively. Over the past 10 years, through July 11th, the S&P Technology sector has posted a total return of 175 percent, while the healthcare sector has provided a total return of 171 percent, according to data from FactSet.

RDI Initiates Coverage on:

ACADIA Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=ACAD

Mylan N.V.
https://ub.rdinvesting.com/news/?ticker=MYL

ACADIA Pharmaceuticals Inc.'s stock moved 4.45% higher Wednesday, to close the day at $27.95. The stock recorded a trading volume of 1,411,993 shares, which was below its three months average volume of 1,520,970 shares. In the last year ACADIA Pharmaceuticals Inc.'s shares have traded in a range of 20.68 - 40.83. The share price has gained 35.15% from its 52 week low. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $27.46 is below its 200-day moving average of $32.02. Shares of ACADIA Pharmaceuticals have fallen approximately 3.09 percent year-to-date.

Access RDI's ACADIA Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=ACAD

On Wednesday, shares in Mylan N.V. recorded a trading volume of 3,249,508 shares, which was below the three months average volume of 5,481,600 shares. The stock ended the day 2.47% higher at 38.58. The stock is currently trading 23.45% below its 52 week high with a 52 week trading range of 33.60 - 50.40.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $38.73 is below its 200-day moving average of $39.16. Shares of the company are trading at a Price to Earnings ratio of 38.54. Shares of Mylan have gained approximately 7.41 percent year-to-date.

Access RDI's Mylan N.V. Research Report at:
https://ub.rdinvesting.com/news/?ticker=MYL

Our Actionable Research on ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) and Mylan N.V. (NASDAQ: MYL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com